» Articles » PMID: 36117721

The Effect of Human Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on Cartilage Repair in Rabbits

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2022 Sep 19
PMID 36117721
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) have shown chondroprotective effects in cartilage repair. However, side effects caused by MSC treatment limit their application in clinic. As a cell-free therapy, MSC-derived exosomes (EXOs) have attracted much more attention in recent years. In the present study, we prepared EXOs from human bone marrow mesenchymal stem cells (hBMSCs) and examined their therapeutic potentials in cartilage repair. Our results showed that the prepared extracellular vesicles exhibit classical features of EXOs, such as cup-like shape, around 100 nm diameter, positive protein markers (CD81, TSG101, and Flotillin 1), and ability of internalization. In primary chondrocytes, the treatment of hBMSC-EXOs markedly increases cell viability and proliferation in a dose-dependent manner. Moreover, wound healing assay showed that hBMSC-EXOs accelerate cell migration in primary chondrocytes. JC-1 staining revealed that the mitochondrial membrane potential was enhanced by hBMSC-EXOs, indicating cell apoptosis was decreased in the presence of hBMSC-EXOs. In rabbits with articular cartilage defects, local administration with hBMSC-EXOs facilitates cartilage regeneration as evidenced by gross view and hematoxylin-eosin (H&E) and Saf-O/Fast Green staining. In addition, the International Cartilage Repair Society (ICRS) score was increased by the application of hBMSC-EXOs. Overall, our data indicate that the treatment with hBMSC-EXOs is a suitable cell-free therapy for treating cartilage defects, and these benefits are likely due to improved cell proliferation and migration in chondrocytes.

Citing Articles

Mesenchymal stromal cells-derived extracellular vesicles in cartilage regeneration: potential and limitations.

Pineiro-Ramil M, Gomez-Seoane I, Rodriguez-Cendal A, Fuentes-Boquete I, Diaz-Prado S Stem Cell Res Ther. 2025; 16(1):11.

PMID: 39849578 PMC: 11755911. DOI: 10.1186/s13287-025-04135-6.


Mesenchymal stem cells and their exosomes mitigate osteoarthritis by restoring the balance between proinflammatory Teffs and Tregs.

Liu T, Ran C, Zhao D, Yang F, Guo Q, Yang J Front Aging. 2024; 5:1509014.

PMID: 39629263 PMC: 11611854. DOI: 10.3389/fragi.2024.1509014.


From Bench to Bedside: The Role of Extracellular Vesicles in Cartilage Injury Treatment.

Jin P, Liu H, Chen X, Liu W, Jiang T Biomater Res. 2024; 28:0110.

PMID: 39583872 PMC: 11582190. DOI: 10.34133/bmr.0110.


The Use of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles in the Treatment of Osteoarthritis: Insights from Preclinical Studies.

Jones M, Jones E, Kouroupis D Bioengineering (Basel). 2024; 11(10).

PMID: 39451337 PMC: 11504680. DOI: 10.3390/bioengineering11100961.


Evaluation of the effect of co-transplantation of collagen-hydroxyapatite bio-scaffold containing nanolycopene and human endometrial mesenchymal stem cell derived exosomes to regenerate bone in rat critical size calvarial defect.

Einabadi M, Izadyari Aghmiuni A, Foroutani L, Ai A, Namini M, Farzin A Regen Ther. 2024; 26:387-400.

PMID: 39045576 PMC: 11263782. DOI: 10.1016/j.reth.2024.02.006.


References
1.
Liu X, Wang L, Ma C, Wang G, Zhang Y, Sun S . Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt/β-catenin signaling pathway. J Orthop Surg Res. 2020; 14(1):470. PMC: 6936129. DOI: 10.1186/s13018-019-1529-7. View

2.
Toh W, Lai R, Hui J, Lim S . MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. Semin Cell Dev Biol. 2016; 67:56-64. DOI: 10.1016/j.semcdb.2016.11.008. View

3.
Makris E, Gomoll A, Malizos K, Hu J, Athanasiou K . Repair and tissue engineering techniques for articular cartilage. Nat Rev Rheumatol. 2014; 11(1):21-34. PMC: 4629810. DOI: 10.1038/nrrheum.2014.157. View

4.
Mustonen A, Nieminen P . Extracellular Vesicles and Their Potential Significance in the Pathogenesis and Treatment of Osteoarthritis. Pharmaceuticals (Basel). 2021; 14(4). PMC: 8065796. DOI: 10.3390/ph14040315. View

5.
Zhang S, Wong K, Ren X, Teo K, Afizah H, Choo A . Mesenchymal Stem Cell Exosomes Promote Functional Osteochondral Repair in a Clinically Relevant Porcine Model. Am J Sports Med. 2022; 50(3):788-800. DOI: 10.1177/03635465211068129. View